<DOC>
	<DOCNO>NCT02138552</DOCNO>
	<brief_summary>The objective clinical trial identify efficacious octenidine dihydrochloride concentration regard bacterial count reduction comparison placebo oral cavity .</brief_summary>
	<brief_title>Dose Finding Study Assess Octenidine Mouthwash Concentrations Comparison Placebo</brief_title>
	<detailed_description />
	<mesh_term>Gingivitis</mesh_term>
	<mesh_term>Octenidine</mesh_term>
	<criteria>Patients mild gingivitis ( mean GI : 0.2 1.0 ) Patients complete natural `` Ramfjordteeth '' replacement teeth Caucasian Signed Informed Consent Patients severe systemic disease ( diabetes , hepatitis , HIV , tuberculosis , cancer ) Patients require endocarditis prophylaxis dental examination treatment Caries require treatment ( e.g . caries cavity ) oral disease ( incl . gingival hyperplasia , diseases oral mucosa , periodontal screen index PSI &gt; 2 ) Patients orthodontic appliance removable denture Patients treat antibiotic less 3 month prior baseline examination V1 and/or treatment plan duration trial Patients chronically treat steroid Patients suffer xerostomia Patients regularly smoke 10 cigarette per day Patients know hypersensitivity allergy test product ingredient medication similar chemical structure Participation patient another clinical trial within last four week enrollment trial Incapability assess essence possible consequence trial ( e.g . alcoholism ) Pregnant breastfeed woman Women childbearing potential except fulfill follow criterion : Postmenopausal ( 12 month natural amenorrhoea 6 month amenorrhoea Serum FSH &gt; 40 U/ml ) Postoperative ( 6 week bilateral ovariectomy without hysterectomy ) Continuous correct application contraception method Pearl Index &lt; 1 % ( e.g . implant , depot , oral contraceptive , intrauterine device IUD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>